Drug Type Small molecule drug |
Synonyms Dabelotine, Dabelotine mesilate, S 12024 + [3] |
Target |
Action agonists |
Mechanism adrenergic receptor agonists(Adrenergic receptors agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC16H26N2O5S |
InChIKeyRSEKRLGWBUABQM-UHFFFAOYSA-N |
CAS Registry153049-48-0 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Alzheimer Disease | Phase 2 | France | 31 Dec 1994 |





